Método de obtención de datos útiles para predecir la respuesta al tratamiento de la Hepatitis C
摘要
<p>The invention relates to the use of the KIR3DS1 gene for predicting or forecasting the response of an individual to the treatment of HCV with peg-IFN in addition to a guanosine analogue, preferably ribavirin (RBV). The invention also relates to a method, a kit and uses.</p>
